VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 209 filers reported holding VERACYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,842,312 | -12.2% | 6,889,490 | +0.2% | 0.00% | -20.0% |
| Q2 2023 | $175,195,956 | +18.9% | 6,878,522 | +4.1% | 0.01% | +25.0% |
| Q1 2023 | $147,295,514 | -5.0% | 6,605,180 | +1.1% | 0.00% | -20.0% |
| Q4 2022 | $155,065,321 | +51.8% | 6,534,569 | +6.2% | 0.01% | +66.7% |
| Q3 2022 | $102,180,000 | -17.9% | 6,155,344 | -1.6% | 0.00% | -25.0% |
| Q2 2022 | $124,422,000 | -26.8% | 6,252,340 | +1.4% | 0.00% | -20.0% |
| Q1 2022 | $169,973,000 | -34.2% | 6,165,118 | -1.7% | 0.01% | -28.6% |
| Q4 2021 | $258,468,000 | -13.1% | 6,273,553 | -2.1% | 0.01% | -12.5% |
| Q3 2021 | $297,531,000 | +16.8% | 6,405,409 | +0.5% | 0.01% | +14.3% |
| Q2 2021 | $254,716,000 | -22.9% | 6,371,062 | +3.7% | 0.01% | -30.0% |
| Q1 2021 | $330,351,000 | +27.8% | 6,146,087 | +16.4% | 0.01% | +25.0% |
| Q4 2020 | $258,448,000 | +55.0% | 5,280,975 | +2.9% | 0.01% | +33.3% |
| Q3 2020 | $166,691,000 | +39.6% | 5,130,519 | +11.3% | 0.01% | +20.0% |
| Q2 2020 | $119,413,000 | +16.5% | 4,610,523 | +9.3% | 0.01% | 0.0% |
| Q1 2020 | $102,518,000 | -14.8% | 4,217,185 | -2.2% | 0.01% | 0.0% |
| Q4 2019 | $120,350,000 | +16.2% | 4,310,534 | -0.1% | 0.01% | +25.0% |
| Q3 2019 | $103,560,000 | -8.9% | 4,314,947 | +8.2% | 0.00% | -20.0% |
| Q2 2019 | $113,692,000 | +63.9% | 3,987,802 | +43.8% | 0.01% | +66.7% |
| Q1 2019 | $69,375,000 | +85.0% | 2,772,740 | -7.0% | 0.00% | +50.0% |
| Q4 2018 | $37,508,000 | +31.0% | 2,981,669 | -0.6% | 0.00% | +100.0% |
| Q3 2018 | $28,638,000 | +46.8% | 2,998,763 | +43.6% | 0.00% | 0.0% |
| Q2 2018 | $19,505,000 | +93.8% | 2,088,336 | +15.4% | 0.00% | – |
| Q1 2018 | $10,066,000 | -16.4% | 1,810,096 | -1.8% | 0.00% | -100.0% |
| Q4 2017 | $12,034,000 | +9.0% | 1,842,981 | +46.3% | 0.00% | 0.0% |
| Q3 2017 | $11,045,000 | +19.3% | 1,259,399 | +13.3% | 0.00% | – |
| Q2 2017 | $9,262,000 | +30.5% | 1,111,901 | +43.8% | 0.00% | – |
| Q1 2017 | $7,099,000 | +118216.7% | 773,323 | +92182.0% | 0.00% | – |
| Q4 2016 | $6,000 | -14.3% | 838 | -8.3% | 0.00% | – |
| Q3 2016 | $7,000 | +600.0% | 914 | +215.2% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 290 | +64.8% | 0.00% | – |
| Q1 2016 | $1,000 | – | 176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |